Selected Grants/Contracts
Optimization of novel molecular target-based drugs for arsenical skin injury, NIH/NIAMS subcontract from University of Alabama at Birmingham.
Excipients to construct and optimize drug delivery systems using 3D printing and nanotechnology, Merck KGaA.
Selected list of invited lectures
Invited lecture on “Transdermal drug delivery”, B.S./M.S. program in Pharmaceutical Sciences, University of Georgia, Athens, GA.
Semisolids to patches to delivery technologies: Unique IVPT challenges as we adapt the Franz cell, presented at Pharma Eds conference on “Transdermal and Intradermal drug delivery systems”, Philadelphia, PA.
“Overcoming challenges facing skin delivery systems and early testing protocols”, invited lecture at Pfizer Consumer Healthcare, Richmond, VA.
Topical and transdermal drug delivery, invited lecture at Bayer HealhCare LLC.
Enabling technologies for dermal delivery of macromolecules, presented at Delivery of actives to skin, Center for Dermal Delivery, NJ.
Skin delivery systems, formulations, and devices, presented at the 8th Clinical Dermatology Congress, Sao Paulo, Brazil.
Facilitated dermal delivery by physical technologies, presented at L’ORÉAL Beauty Devices, Pacific Bioscience Laboratories, Inc., Redmond, WA.
Invited lecture on “Microneedle and iontophoresis based products”, presented at the 5th International conference on Clinical and Experimental Dermatology, New Orleans.
Invited lecture on “Getting macromolecules into the skin – what works?”, Nucleic acid delivery devices for HIV vaccines, workshop organized by National Institutes of Health, Bethesa, MD.
“Getting proteins across the skin – what works?”, Biologics Formulation and Delivery Summit, organized by CHI at Annual PEGS conference, Boston, MA.
“Human skin as an in vitro surrogate model for bioequivalence comparison of topicals”, International Conference and Exhibition on Biowaivers and Biosimilars, Raleigh, NC.
“Non-traditional and traditional approaches for delivery into/through skin: What’s new?”, Glaxo Smith Kline, Parsippany, NJ.
Invited lecture on “Challenges in bringing to the market the next generation passive and especially active transdermal drug delivery systems”, presented at the Annual meeting of the Controlled Release Society in educational workshop, “Considerations for future regulatory submissions of transdermal products”, Quebec City, Canada.
Microneedles: Pore closure and drug transport, invited speaker/panelist on roundtable on minimally invasive transdermal delivery of biotherapeutics, AAPS National Biotechnology Conference, San Diego, CA.
Physical stability challenges for drug-device combination products: Conventional patches and active technology transdermals, invited lecture at the AAPS annual meeting, Washington, D.C.
Invited lecture on “Transdermal Delivery – The complete picture”, presented at the University of North Carolina School of Pharmacy.
Invited lecture on “Physical Enhancement Technologies for Transdermal Delivery of Bioactive Materials”, presented at the 38th annual meeting of the Controlled Release Society, National Harbor, Maryland.
Transdermal delivery of biologics, invited lecture and round table discussion at Pfizer, St. Louis, MO.
Invited lecture on “Pore Closure and Drug Transport in Skin Treated with Maltose Microneedles” in the International Conference on Microneedles. Georgia Tech, Atlanta.
Invited lecture on “New Technologies to Allow Transdermal Delivery of Biopharmaceuticals” for “Drug Delivery” at the International Conference on Drug Discovery and Therapy, Dubai, UAE.
Invited keynote speech on “New technologies to allow Transdermal delivery of therapeutic proteins and small water soluble drugs” at the Annual Congress of International Drug Discovery Science and Technology, Shanghai, China.
Absorption of biologic drugs, invited lecture at the AAPS National Biotechnology Conference Short Course on “Where did my biologic go – and why ?”, San Diego, CA.
New enhancement technologies for transdermal delivery of proteins, invited lecture at the Center for Disease Control (CDC).
New technologies to allow transdermal delivery of therapeutic proteins and small water soluble drugs, invited lecture at Pfizer, Ann Arbor, MI.
Transdermal delivery of proteins, invited lecture at the AAPS National Biotechnology Conference, Boston, MA.
Transdermal delivery of proteins, invited lecture at the AAPS annual meeting, Nashville, TN.
Enhancement technologies for transdermal delivery, invited lecture at the Food and Drug Administration, Silver Springs, MD.
Consultant (now or in the past)
Abbott/ AbbVie
Agile Therapeutics, Princeton, NJ
Altea Therapeutics, Atlanta, GA
Bayer Healthcare/Maven
Demegen, Inc., Durham, NC
DiTeba Research Labs, ON, Canada
Empi, Inc., St. Paul, MN
Eurand America, Dayton, OH
Genetronics, Inc., San Diego, CA
Glaxo Smith Kline, Parsipanny, NJ
Johnson & Johnson subsidiary, CA
L’ORÉAL Beauty Devices/ Pacific Bioscience Labs, Inc.
Mallinckrodt/ Covidien
Murty Pharmaceuticals, Inc, Lexington, KY
Novartis (Basel, Switzerland)
NuPathe Inc., Philadelphia, PA
Penwest, Danbury, CT
Pfizer Consumer Heatlh
Pfizer, Inc.
Regeneron Pharmaceuticals, Inc.
SkinMedica Inc., Carlsbad, CA
Solvay Pharmaceuticals, Marietta, GA
Transport Pharmaceuticals, Framingham, MA
Travanti Pharma, MN
Procter & Gamble Co., Cincinnati, OH
Xenexus Pharmaceuticals, Australia